Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Rubén Osuna‐Gómez"'
Autor:
Anna Brujats, Anna Huerta, Rubén Osuna-Gómez, Albert Guinart-Cuadra, Andreu Ferrero-Gregori, Clàudia Pujol, German Soriano, Maria Poca, Javier Fajardo, Angels Escorsell, Adolfo Gallego, Silvia Vidal, Càndid Villanueva, Edilmar Alvarado-Tapias
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 15, p 8302 (2024)
Advanced chronic liver disease (ACLD) is associated with a wide spectrum of immune dysfunction. The clinical impact of SARS-CoV-2 on the development of decompensation and immune response in unvaccinated outpatients has not as yet been clearly defined
Externí odkaz:
https://doaj.org/article/1dca3e66222747cf90725d8bd814c42e
Autor:
Georgia Anguera, Maria Mulet, Carlos Zamora, Rubén Osuna-Gómez, Andrés Barba, Ivana Sullivan, Jorgina Serra-López, Elisabet Cantó, Silvia Vidal, Margarita Majem
Publikováno v:
Biomedicines, Vol 12, Iss 5, p 958 (2024)
PD-(L)1 inhibitors are part of the treatment strategy for non-small cell lung cancer (NSCLC) although its efficacy is limited to certain patients. Our study aimed to identify patients who might benefit from anti-PD-(L)1 inhibitors by analyzing the PD
Externí odkaz:
https://doaj.org/article/1743b63c341c4a9a946584a3e7e487fc
Autor:
Rubén Osuna-Gómez, Maria Mulet, Silvia Barril, Elisabet Cantó, Paloma Millan-Billi, Ana Pardessus, David de la Rosa-Carrillo, Diego Castillo, Silvia Vidal
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4297 (2024)
Interstitial lung diseases (ILDs) are characterized by inflammation or fibrosis of the pulmonary parenchyma. Despite the involvement of immune cells and soluble mediators in pulmonary fibrosis, the influence of antimicrobial peptides (AMPs) remains u
Externí odkaz:
https://doaj.org/article/7bb139260b12437da5a1e1cb9ff10d0e
Autor:
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, Rubén Osuna-Gómez, Ariadna Tibau, Olga Lidia Bell, Teresa Ramón y Cajal, Enrique Lerma, Bárbara Lobato-Delgado, Juliana Salazar, Agustí Barnadas
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 5, p 2627 (2024)
Currently, therapy response cannot be accurately predicted in HER2-negative breast cancer (BC). Measuring stromal tumour-infiltrating lymphocytes (sTILs) and mediators of the tumour microenvironment and characterizing tumour-infiltrating immune cells
Externí odkaz:
https://doaj.org/article/baf94fe71b514c658bce72909c8222af
Autor:
Rubén Osuna-Gómez, Ivan Castellví, Maria Mulet, Mª Àngels Ortiz, Douglas E. Brough, Helen Sabzevari, Roshanak T. Semnani, Silvia Vidal
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10567 (2023)
This study investigated the role of IL-35 in systemic sclerosis (SSc) patients, focusing on CD4+ T cell response and immunomodulatory cytokine production. By comparing the cytokine levels in healthy donors (HD) and SSc patients using ELISAs, we found
Externí odkaz:
https://doaj.org/article/774cabab10f841669e7c2c15f77c5d2c
Autor:
Miriana d’Alessandro, Sara Gangi, Piera Soccio, Elisabet Cantó, Rubén Osuna-Gómez, Laura Bergantini, Paolo Cameli, Gaia Fabbri, Sara Croce, Giulia Scioscia, Giusy Montuori, Matteo Fanetti, Giorgia Moriondo, Fabrizio Mezzasalma, Diego Castillo, Donato Lacedonia, Silvia Vidal, Elena Bargagli
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 4, p 4071 (2023)
Diagnosis of interstitial lung diseases (ILD) is difficult to perform. Extracellular vesicles (EVs) facilitate cell-to-cell communication, and they are released by a variety of cells. Our goal aimed to investigate EV markers in bronchoalveolar lavage
Externí odkaz:
https://doaj.org/article/9fcd5f00e0d940588d12496042566895
Autor:
Rubén Osuna‐Gómez, Silvia Barril, Maria Mulet, Carlos Zamora Atenza, Paloma Millan‐Billi, Ana Pardessus, Douglas E. Brough, Helen Sabzevari, Roshanak T. Semnani, Diego Castillo, Silvia Vidal
Publikováno v:
Immunology. 168:610-621
Pulmonary fibrosis involves various types of immune cells and soluble mediators, including TGF-β and IL-35, a recently identified heterodimeric cytokine that belongs to the IL-12 cytokine family. However, the effect of regulatory IL-35 may play an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802230165148433efdeacd40c5db8389
https://doi.org/10.1111/imm.13596
https://doi.org/10.1111/imm.13596
Autor:
Vidal, Rubén Osuna-Gómez, Ivan Castellví, Maria Mulet, Mª Àngels Ortiz, Douglas E. Brough, Helen Sabzevari, Roshanak T. Semnani, Silvia
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10567
This study investigated the role of IL-35 in systemic sclerosis (SSc) patients, focusing on CD4+ T cell response and immunomodulatory cytokine production. By comparing the cytokine levels in healthy donors (HD) and SSc patients using ELISAs, we found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::699bda299c5f393e2705d1a3b54ee439
Autor:
Rubén Osuna-Gómez, Cristina Arqueros, Carla Galano, Maria Mulet, Carlos Zamora, Agustí Barnadas, Silvia Vidal
Publikováno v:
Cancers, Vol 13, Iss 6167, p 6167 (2021)
Cancers; Volume 13; Issue 24; Pages: 6167
Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universidad Europea (UEM)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Cancers; Volume 13; Issue 24; Pages: 6167
Cancers
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universidad Europea (UEM)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Simple Summary This study contributes to the characterization of CD8+ HLA-DR+ T cell mediated-mechanisms involved in the anti-tumor response in breast cancer patients who respond to neoadyuvant chemotherapy (NACT). Cultures with plasma from responder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b022c438fa5994742f3b8add400dde5
https://www.mdpi.com/2072-6694/13/24/6167
https://www.mdpi.com/2072-6694/13/24/6167
Autor:
Osuna‐Gómez, Rubén1 (AUTHOR), Barril, Silvia2,3 (AUTHOR), Mulet, Maria1 (AUTHOR), Zamora Atenza, Carlos1 (AUTHOR), Millan‐Billi, Paloma3,4 (AUTHOR), Pardessus, Ana3 (AUTHOR), Brough, Douglas E.5 (AUTHOR), Sabzevari, Helen5 (AUTHOR), Semnani, Roshanak T.5 (AUTHOR), Castillo, Diego1,2,3 (AUTHOR), Vidal, Silvia1 (AUTHOR) svidal@santpau.cat
Publikováno v:
Immunology. Apr2023, Vol. 168 Issue 4, p610-621. 12p.